Who is sponsoring NCT05323851?

NCT05323851 is sponsored by University of Rome Tor Vergata.

What condition does NCT05323851 study?

NCT05323851 studies COVID-19, Health Behavior.

What drugs are being tested in NCT05323851?

Interventions: COVID-surg-SPIGC questionnaire.

What is the status of NCT05323851?

NCT05323851 is currently COMPLETED.

Last reviewed 2022-11-21 · How we verify

How Future Surgery Will Benefit From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Measures Perspective From Italian Young Surgeon Society (SPIGC)

NCT05323851 COMPLETED

The coronavirus 2019 pandemic (COVID-19) strongly affected clinical care worldwide. Due to a shortage of hospitals and beds in intensive care units (ICU), in Italy during outbreaks, surgical resources were temporarily and partially shifted to COVID-19 patients. In addition, the risk of cross-infection could have determined a shit in surgical perioperative care. To counterbalance these limitations, many centers routinely changed their clinical practice, which could be maintained by surgeons across Italy. The aim of the present study is to evaluate how the COVID-19 pandemic determined a change in daily clinical practice among all specialties.

Details

Lead sponsor	University of Rome Tor Vergata
Status	COMPLETED
Enrolment	581
Start date	Wed Mar 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jul 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

COVID-19
Health Behavior

Interventions

COVID-surg-SPIGC questionnaire

Countries

Italy